Ann K. Shuman '96 Promoted to Senior Leadership of CME Group's Legal & Regulatory Team

CME Group, the world's largest and most diverse derivatives marketplace, today announced several new senior leadership appointments to its Legal & Regulatory Team. Ann K. Shuman, Managing Director & Deputy General Counsel, has been promoted to an expanded role that will include legal support for regulatory policy initiatives and key growth activities. Shuman will continue reporting to Kathleen Cronin, Managing Director, General Counsel and Corporate Secretary.

In her expanded role, Shuman, 41, who has been with CME Group since 2000, will be responsible for leading the company's legal function with respect to regulatory policy. Additionally, she will continue to oversee legal support for new business transactions, including negotiating and constructing strategic investments, partnerships and M&A activity. Shuman has served as Managing Director and Deputy General Counsel of CME Group since July 2007. She previously served as Managing Director, Corporate Development, where she was responsible for developing and negotiating key strategic partnerships. Shuman has been instrumental in completing many complex commercial transactions and joint ventures, including CME's historic commercial agreements with CBOT for clearing and NYMEX for electronic trade matching, CME's alliance with BM&FBOVESPA, and the company's license agreements with The Nasdaq Stock Market, Inc. and Standard & Poor's. Before joining the company, Shuman worked as an Associate in the Derivatives and Investment Products Group of Sidley & Austin in Chicago. She holds a bachelor's degree in English from Trinity University in San Antonio, Texas and a J.D. from the University of Chicago Law School.